The mental health field has five top issues which affect 80 million Americans: stress, anxiety, depression, dementia and inattention.

The mental health field has five top issues which affect 80 million Americans: stress, anxiety, depression, dementia and inattention.

Problem

Pharmaceutical drugs currently used to treat mental health issues, such as Prozac, Valium and Ritalin, often carry serious side effects which limit their use.

Problem

Pharmaceutical drugs currently used to treat mental health issues, such as Prozac, Valium and Ritalin, often carry serious side effects which limit their use.

Solution

Our solution is to use an innovative approach – RNA therapies – to treat mental health issues without known side effects, allowing us to serve a larger market with more effective treatments.

Solution

Our solution is to use an innovative approach – RNA therapies – to treat mental health issues without known side effects, allowing us to serve a larger market with more effective treatments.

Scalability

Our genetic anti-depressant is just the first of a series of techniques that promises to revolutionize the treatment of mental health. After demonstrating efficacy with depression, we will apply our technology to alleviate cognitive issues affecting 80 million Americans, including, stress, anxiety, attention deficit disorder (ADD), obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorder, personality disorders, and memory concerns.

Scalability

Our genetic anti-depressant is just the first of a series of techniques that promises to revolutionize the treatment of mental health. After demonstrating efficacy with depression, we will apply our technology to alleviate cognitive issues affecting 80 million Americans, including, stress, anxiety, attention deficit disorder (ADD), obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorder, personality disorders, and memory concerns.

Positive Outcomes

By ameliorating the neurological conditions which characterize excessive anxiety and depression, Cognigenics RNA therapies will help patients to return to natural states of greater optimism, emotional balance, relaxation and clarity.

Positive Outcomes

By ameliorating the neurological conditions which characterize excessive anxiety and depression, Cognigenics RNA therapies will help patients to return to natural states of greater optimism, emotional balance, relaxation and clarity.

Results are achieved by optimizing neuron performance to enhance cognition using CRISPR.

Our novel treatment method is protected by multiple patents pending and holds the promise of significant rewards in a rapid development timeframe.

Results are achieved by optimizing neuron performance to enhance cognition using CRISPR.

Our novel treatment method is protected by multiple patents pending and holds the promise of significant rewards in a rapid development timeframe.